Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of July 26, 2026, XLO trades at $8.65 with a market cap of $56.87M and a P/E ratio of -2.00. XLO moved +2.77% today. Year to date, XLO is -3.49%; over the trailing twelve months it is -10.47%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $8.65 |
| Market Cap | $56.87M |
| P/E Ratio | -2.00 |
| EPS | $-4.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.80 |
| 52-Week Low | $6.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $53.48M |
| Net Income | $-31.30M |
| Gross Margin | 0.00% |
XLO analyst coverage data. Average price target: $0.00.